Zayd A Razouki, MD, MS
Department of General Internal Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Deputy Section Chief, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2014 | School of Public Health, Boston University, Boston, Massachusetts, US, Health Service Research, M.S |
| 2003 | Baghdad Medical College, The University of Baghdad, Baghdad, IQ, MD |
Postgraduate Training
| 2024-2025 | Diplomate of the American Board of Obesity Medicine Board Certification, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2024-2025 | LEADing Others Accelerate Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2024-null | LEADing Others Core Curriculum, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2022-null | Clinical Safety and Effectiveness (CS&E) Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2014-2016 | Research Fellowship, Health Service Research Fellow, Durham VA Medical Center, Durham, North Carolina |
| 2012-2014 | Clinical Residency, Preventive Medicine, Boston Medical Center/Edith Nurse Rogers Memorial (ENRM) VAMC, Bedford, Massachusetts |
| 2009-2012 | Clinical Residency, Internal Medicine, Norwalk Hospital / Yale Affiliated Program, Norwalk, Connecticut |
| 2003-2006 | Clinical Internship, Ministry of Health, Baghdad |
Licenses & Certifications
| 2024 | Texas Medical Board |
| 2023 | American Board of Preventive Medicine |
| 2023 | American Board of Internal Medicine |
| 2016 | Minnesota Medical Board |
| 2014 | North Carolina Medical Board |
| 2013 | Massachusetts Medical Board |
Experience & Service
Faculty Academic Appointments
Assistant Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2023
Consultant, Department of Internal Medicine, Mayo Clinic, Rochester, MN, 2019 - 2020
Assistant Professor, Division of Internal Medicine, Mayo Clinic Alix Medical School and Science, Rochester, MN, 2017 - 2020
Sr. Consultant/ Sr. Associate, Internal Medicine, Mayo Clinic Alix Medical School and Science, Rochester, MN, 2016 - 2019
Administrative Appointments/Responsibilities
Co-Lead Survivorship Research Priority Theme Workgroup, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Other Professional Positions
Member of Obesity of Medical Association- Clinician Training Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Present Co-Lead of The Transition of care clinic and it’s impact on unplanned re admissions QI Project, The University of Texas MD Anderson Cancer Center, 2023 - Present
Director of Ambulatory Operations for Consultative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Leader of QI project, developing a Clinical Pathway for Patients with Metabolic Syndrome, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, 2021 - 2022
Member of QI Project, Hospital Medicine Delirium Project-P4, The University of Texas MD Anderson Cancer Center, Houston, 2021 - 2022
Director, General Internal Medicine Clinical and Research Conference, The University of Texas MD Anderson Cancer Center, Houston, 2021 - 2023
Triage Improvement Work Group, Mayo Clinic, Rochester, MN, 2019 - 2019
Division of General Internal Medicine Research Committee, Mayo Clinic, Rochester, MN, 2019 - 2020
Division of General Internal Medicine Quality Work Group, Mayo Clinic, Rochester, MN, 2019 - 2020
Appointed - Quality Academy Faculty, Mayo Clinic, Rochester, MN, 2018 - 2020
Faculty of Internal Medicine Residency Program, Mayo Clinic, Rochester, MN, 2017 - 2020
Appointed - Faculty of Internal Medicine Residency Program, Mayo Clinic, Rochester, MN, 2017 - 2020
Lead - Implementing Depression and Anxiety Screening questionnaire in Executive, Development, and Internal Practice. Gold Project, Mayo Clinic, Rochester, MN, 2017 - 2017
Improving Discharge Summaries for Internal Medicine Residents, Norwalk Hospital, Norwalk, CT, 2011 - 2012
Division of General Internal Medicine Diversity and Inclusion Committee, Mayo Clinic, Rochester, MN, 2008 - 2020
Intramural Institutional Committee Activities
Member, Academic Review Committee- 2026 Trainee Day – Flash Talk Competition, The University of Texas MD Anderson Cancer Center, 2026
Extramural Institutional Committee Activities
Member, Cancer Survivorship Steering Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Clinical Safety & Effectiveness Program, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Academic Review Committee for the Division of Education & Training, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Advanced Breast Cancer Steering Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Junior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2021 - 2024
Member, Institutional Algorithms, The University of Texas MD Anderson Cancer Center
Member, Neutropenic Fever - Outpatient, The University of Texas MD Anderson Cancer Center
Member, Obesity Screening and Management – Adult, The University of Texas MD Anderson Cancer Center
Editorial Activities
Editorial Review Board Member, American Journal of Health Behavior, 2019
Honors & Awards
| 2023 | Winner of Division of Internal Medicine Excellence Award in Quality, The University of Texas MD Anderson Cancer Center |
| 2020 | COVID Frontline Care Team (CFCT), Mayo Clinic General Internal Medicine Division |
| 2016 | Best Poster Presentation (2nd Place), Institute for Medical Research - Durham VA Medical Center |
| 2014 | ICARE Aware for Respect, VISIN One, Veterans Health Administration |
| 2013 | Honorable Mention for Best Abstract at Evans Day, Boston University |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. GLP-1 Use in Oncology Patients. Invited. MD Anderson at Cooper Presentation. Houston, Texas, US.
- 2026. Obesity and Overweight Management. Invited. Houston, Texas, US.
- 2026. Research Priority Collaboration Discussion: Obesity Cancer Survivorship Research Retreat. Invited. Houston, Texas, US.
- 2026. Obesity Cancer Survivorship Research Retreat. Houston, Texas, US.
- 2025. A Transition of Care Clinic and its impact on unplanned hospital readmissions. Internal Medicine & Cancer Survivorship Grand Rounds. Houston, Texas, US.
- 2025. Obesity Past, Present and Future in Cancer Survivors. Invited. 2025 Cancer Survivorship Research Retreat. Houston, TX, US.
- 2025. Obesity Management post-cancer: Pharmacologic and Lifestyle Interventions. Invited. MD Anderson and RUSH Cancer Survivorship ECHO Survivorship. Houston, Texas, US.
- 2022. Patient Safety Update And Screening For And Management Of Metabolic Syndrome In General Internal Medicine Clinic. Conference. Internal Medicine & Cancer Survivorship Grand Rounds. Houston, TX, US.
- GLP-1 and GLP/GIP Agonist Incretin Based Therapy Overview. Invited. Houston, Texas, US.
National Presentations
- 2025. Abstract P4-01-12: Advanced Breast Cancer, Comorbidities, and Overall Survival: An Integrated Review. Conference. AACR. Houston, Texas, US.
- 2025. Effect of metabolic syndrome on survival among patients with breast or prostate cancer. Conference. 2025 ASCO Annual Meeting. Houston, Texas, US.
- 2025. ADVANCED BREAST CANCER PATIENT ADVOCATES DELIVER PATIENT EMPOWERMENT: ABCDE PRE-INTERVENTION QUALITATIVE INTERVIEW ANALYSIS. Conference. 2025 Oncology Nursing Society. Houston, Texas, US.
- 2022. Effect of metabolic syndrome on survival among patients with breast or prostate cancer. Conference. 2022 Asco Annual Meeting. Houston, Texas, US.
- 2022. Prevalence and Factors Associated with Non-Alcoholic Fatty Liver Disease (NALFD) in Lean Individuals Detected by Vibration Controlled Transient Elastography Among US Adults: results from NHANES 2017-2018. Conference. Prevalence and Factors Associated with Non-Alcoholic Fatty Liver Disease (NALFD) in Lean Individuals Detected by Vibration Controlled Transient Elastography Among US Adults: results from NHANES 2017-2018. Orlando, FL, US.
- 2019. Updates in Herbs and Supplements. Conference. Mayo Clinic Integrative Medicine Health Conference. Wisconsin Dell, WI, US.
- 2019. Patients’ Perspective on Chronic Opioid Treatment in Primary Care. Conference. Addiction Health Service Research Conference. Salt Lake, UT, US.
- 2018. Attributes, Attitudes, and Practices of Clinicians Concerned with Opioid Prescribing. Conference. Addiction Health Services Research Conference. Savannah, GA, US.
- 2018. A Practical and Safe Approach to Supplements Integrative Medicine and Health. Invited. Integrative Medicine and Health Conference. Phoenix, AZ, US.
- 2016. Patient Level Factors Associated with Post-Emergency Department Observation Stays in a Medicare Population. Conference. Society of General Internal Medicine. Hollywood, FL, US.
- 2016. The Acute Evaluation of Syncope: Variation in Hospital Admission Practices and in Ordering Low Value Neurologic Diagnostic Testing. Conference. Society of General Internal Medicine. Hollywood, FL, US.
- 2016. Do Primary Care Clinics with Higher Adoption Levels of Patient Centered Medical Home Features have Lower ED Return Visits?. Conference. Society of General Internal Medicine. Hollywood, FL, US.
- 2015. Diabetes Control in Financially Distressed Patients: A Potential Solution. Conference. Academy of Health Annual Research Meeting. Minneapolis, MN, US.
- 2014. Comparing Anticoagulation Measures. Conference. Society of General Internal Medicine. San Diego, CA, US.
- 2013. Understanding Time Above and Below Time in Therapeutic Range. Conference. Society of General Internal Medicine. Denver, CO, US.
- 2011. First Survivor of Hydralazine Induced Pulmonary-Renal Syndrome: Case Report. Conference. American College of Physician, Chapter Meeting. Southington, CT, US.
- 2010. Langerhan Histocytosis: Case Report. Conference. American College of Physician, Chapter Meeting. Southington, CT, US.
International Presentations
- 2026. Metabolic Syndrome is Associated with Increased Mortality In Patients with Breast or Prostate Cancer. Conference. MASCC/ISOO 2026 Annual Meeting. Melbourne, AU.
- Weight Trajectories in Patients Treated with Immune Checkpoint Inhibitors: A Large Single-Center Retrospective Study. Conference. MASCC/ISOO 2026. Melbourne, AU.
Grant & Contract Support
| Date: | 2025 - Present |
| Title: | Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men with Intermediate Risk Prostate Cancer: A Pilot Feasibility Study |
| Funding Source: | N/A |
| Role: | Co-I |
| Title: | Engaging the Patient Community in Research and Publications |
| Funding Source: | Pfizer |
| Role: | PI |
| ID: | 77668369 |
Selected Publications
Peer-Reviewed Articles
- Hwang JP, Zhang N, Misoi MW, Gull S, Razouki ZA, Gregg JR, Heredia NI, Giordano SH. Metabolic syndrome is associated with increased mortality in patients with breast or prostate cancer. Sci Rep, 2026. e-Pub 2026. PMID: 42443263.
- Berkman AM, Andersen CR, Dixon SB, Ramirez A, Gilmore K, Thoman W, Razouki ZA, Santos D, Thosani S, Livingston JA, Hildebrandt MAT, Roth ME. Weight-Related Outcomes Among Survivors of Adolescent and Young Adult Cancer after Anti-Obesity Medication Initiation. J Adolesc Young Adult Oncol 15(1):69-73, 2026. e-Pub 2026. PMID: 40452567.
- Martinez Leal I, Pillai AB, Foreman JT, Siu KW, Heredia NI, Escalante CP, Manzullo EF, Christie AJ, Lacourt TE, Razouki ZA, Hwang JP. A Qualitative Study of the Knowledge of Metabolic Syndrome, Attitudes about Lifestyle Modifications, and Preferences for Lifestyle Interventions among Patients with Cancer and Metabolic Syndrome. Cancers (Basel) 16(18), 2024. e-Pub 2024. PMID: 39335119.
- Martinez Leal I, Pillai AB, Foreman JT, Siu KW, Heredia NI, Escalante C, Manzullo EF, Christie AJ, Lacourt TE, Razouki ZA, Hwang JP. A Qualitative Study of Knowledge of Metabolic Syndrome, Attitudes about Lifestyle Modifications, and Preferences for Lifestyle Interventions among Patients with Cancer and Metabolic Syndrome. Res Sq, 2023. e-Pub 2023. PMID: 37720029.
- Razouki ZA, Zhang X, Hwang JP, Heredia NI. Clinical Factors Associated with Non-Obese Nonalcoholic Fatty Liver Disease Detected among US Adults in the NHANES 2017-2018. J Clin Med 11(15), 2022. e-Pub 2022. PMID: 35893351.
- Razouki Z, Khokhar BA, Philpot LM, Ebbert JO. Attributes, Attitudes, and Practices of Clinicians Concerned with Opioid Prescribing. Pain Med 20(10):1934-1941, 2019. e-Pub 2019. PMID: 30403814.
- Gierisch JM, Hughes JM, Edelman D, Bosworth HB, Oddone EZ, Taylor SS, Kosinski AS, McDuffie JR, Swinkels CM, Razouki Z, Masilamani V, Nagi A, Wing L. The Effectiveness of Health Coaching. Department of Veteran Affairs - Health Services Research & Development- Evidence-based Synthesis Program Reports, 2017. e-Pub 2017. PMID: 29553632.
- Razouki Z, Knighton T, Martinello RA, Hirsch PR, McPhaul KM, Rose AJ, McCullough M. Organizational factors associated with Health Care Provider (HCP) influenza campaigns in the Veterans health care system: a qualitative study. BMC Health Serv Res 16:211, 2016. e-Pub 2016. PMID: 27378468.
- Pavon JM, Adam SS, Razouki ZA, McDuffie JR, Lachiewicz PF, Kosinski AS, Beadles CA, Ortel TL, Nagi A, Williams JW Jr. Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-Risk Surgical Patients: A Systematic Review. J Arthroplasty 31(2):524-32, 2016. e-Pub 2016. PMID: 26525487.
- Rose AJ, Reisman JI, Razouki Z, Ozonoff A. Percent Time in Range with Warfarin as a Performance Measure: How Long a Sampling Frame Is Needed?. Jt Comm J Qual Patient Saf 41(12):561-8, 2015. e-Pub 2015. PMID: 26567146.
- Razouki Z, Burgess JF, Ozonoff A, Zhao S, Berlowitz D, Rose AJ. Improving Anticoagulation Measurement Novel Warfarin Composite Measure. Circ Cardiovasc Qual Outcomes 8(6):600-7, 2015. e-Pub 2015. PMID: 26420820.
- Razouki Z, Ozonoff A, Zhao S, Jasuja GK, Rose AJ. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range. Circ Cardiovasc Qual Outcomes 7(5):664-9, 2014. e-Pub 2014. PMID: 25185245.
- Razouki Z, Ozonoff A, Zhao S, Rose AJ. Pathways to poor anticoagulation control. J Thromb Haemost 12(5):628-34, 2014. e-Pub 2014. PMID: 24548552.
Review Articles
- Fang A, Frigo DE, Hahn A, Razouki Z, Hwang J, Koutroumpakis E, Lawen T, Smith M, Hamilton-Reeves J, DiGiovanni J, Higgason N, Garcia RS, Chapin BF, Pettaway C, Chery L, Troncoso P, Logothetis C, Daniel CR, Wei P, Gregg JR. GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials. Urology 201:152-158, 2025. e-Pub 2025. PMID: 40348027.
- Razouki ZA, Ali NT, Nguyen VQ, Escalante CP. Risk factors associated with venous thromboembolism in breast cancer: a narrative review. Support Care Cancer 30(10):8589-8597, 2022. e-Pub 2022. PMID: 35511300.
- Riley IL, Murphy B, Razouki Z, Krishnan JA, Apter A, Okelo S, Kraft M, Feltner C, Que LG, Boulware LE. A Systematic Review of Patient- and Family-Level Inhaled Corticosteroid Adherence Interventions in Black/African Americans. J Allergy Clin Immunol Pract 7(4):1184-1193.e3, 2019. e-Pub 2019. PMID: 30395992.
- Ko D, Razouki Z, Otis J, Marulanda-Londoño E, Hylek EM. Anticoagulation reversal in vitamin K antagonist-associated intracerebral hemorrhage: a systematic review. J Thromb Thrombolysis 46(2):227-237, 2018. e-Pub 2018. PMID: 29687299.
- Alahdab F, Farah W, Almasri J, Barrionuevo P, Zaiem F, Benkhadra R, Asi N, Alsawas M, Pang Y, Ahmed AT, Rajjo T, Kanwar A, Benkhadra K, Razouki Z, Murad MH, Wang Z. Treatment Effect in Earlier Trials of Patients With Chronic Medical Conditions: A Meta-Epidemiologic Study. Mayo Clin Proc 93(3):278-283, 2018. e-Pub 2018. PMID: 29477781.
- Pavon JM, Williams JW Jr, Adam SS, Razouki ZA, McDuffie JR, Lachiewicz PF, Kosinski AS, Beadles CA, Ortel TL, Nagi A. Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-risk Surgical and Medical Patients, 2015. e-Pub 2015. PMID: 26677487.
Other Articles
- Alahdab F, Arwani R, Pasha AK, Razouki ZA, Prokop LJ, Huber TS, Murad MH A systematic review and meta-analysis of endovascular versus open surgical revascularization for chronic mesenteric ischemia. J Vasc Surg 67(5):1598-1605, 2018. PMID: 29571626.
Book Chapters
- De Beer KD, Buckley CA, La Cruz HID, La Cruz MGD, Palma DA, Razouki ZA, Stephen J, Taylor EL, Hwang JP. Contribution: 9. Lifestyle Factors. In: Oncologic Emergency Medicine: Principles and Practice, 2026.
Books (edited and written)
- Agrwal N, Khera N, Matulis J, Mundell W, Razouki Z. Value in Health Care. Elsevier, 2019.
Patient Reviews
CV information above last modified September 09, 2026